Single–dose pharmacokinetics of labetalol in healthy young men
- 12 January 1982
- journal article
- clinical trial
- Published by Wiley in Acta Medica Scandinavica
- Vol. 212 (S665) , 67-73
- https://doi.org/10.1111/j.0954-6820.1982.tb00410.x
Abstract
Single doses of labetalol (200 mg i.v. over 5 min, 200 and 400 mg orally) were given to five healthy men on three different occasions. Plasma levels were followed for up to 25 h and blood pressure for 5 h. The elimination half-life was 1.6 to 8.5 h for the first 8 h. The oral bioavailability ranged from 4 to 23%. All doses induced a significant fall in systolic blood pressure at 2 h, the peak effect occurring at 30--120 (mean 63-72) min. After intravenous administration the peak supine blood-pressure fall was significant for both systolic and diastolic blood pressure and occurred 16 min after administration.Keywords
This publication has 6 references indexed in Scilit:
- Effect of food on the bioavailability of labetalol.Published by Wiley ,1980
- Pharmacokinetics and pharmacodynamic studies of labetalol in hypertensive subjects.Published by Wiley ,1979
- Labetalol: Bioavailability, Drug Plasma Levels, Plasma Renin and Catecholamines in Acute and Chronic Treatment of Resistant HypertensionAustralian and New Zealand Journal of Medicine, 1978
- Decreased first-pass metabolism of labetalol in chronic liver disease.BMJ, 1978
- AUTOMATIC BLOOD-PRESSURE RECORDINGThe Lancet, 1977
- Relationship between plasma concentrations and pharmacological effects of labetalolEuropean Journal of Clinical Pharmacology, 1977